Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Mona Thakre"'
Autor:
Bassem Yamout, Raed Alroughani, Jihad Inshasi, Samar Farouk, Fatema Abdulla, Namareq Y. Al-Jarki, Abdulla Alasmi, Sarmad Al Fahad, Jaber Alkhabouri, Khalid Al-Saffar, Beatrice Benedetti, Beatriz Canibano, Dirk Deleu, Ali Hassan, Pournamy Sarathchandran, Ahmed Shatila, Mohammad Abouelnaga, Mona Thakre, Miklos Szolics, Amir Boshra
Publikováno v:
Neurology and Therapy, Vol 13, Iss 5, Pp 1321-1335 (2024)
Abstract Cladribine tablets (CladT), like alemtuzumab, acts as an immune reconstitution therapy. However, CladT is administered orally (alemtuzumab is given by infusion) and without the potential for serious side effects that limit the therapeutic us
Externí odkaz:
https://doaj.org/article/a456e8fecb904caa838b18d50372bc33
Autor:
Jihad Inshasi, Samar Farouk, Ahmed Shatila, Ali Hassan, Miklos Szolics, Mona Thakre, Deeb Kayed, Derk Krieger, Abubaker Almadani, Taoufik Alsaadi, Beatrice Benedetti, Victoria Mifsud, Anu Jacob, Shatha Sayegh, Amir Boshra, Raed Alroughani
Publikováno v:
Neurology and Therapy, Vol 12, Iss 4, Pp 1309-1318 (2023)
Abstract Introduction Inconvenient administration and side effects of some disease-modifying therapies (DMTs) for relapsing multiple sclerosis (RMS) can deter adherence. We evaluated treatment satisfaction with cladribine tablets (CladT) for RMS in t
Externí odkaz:
https://doaj.org/article/920f402b94c34212b388eaf7282a5af9
Autor:
Victoria Ann Mifsud, Ajit Kumar, Ali Hassan, Miklos Szolics, Tayseer Mohammed Zein, Mustafa Shakra, Taoufik Alsaadi, Suzan Ibrahim Nouri, Ahmed Shatila, Mona Thakre, Amir Boshra, Sarmed Alfahad, Jihad Inshasi
Publikováno v:
Neurology and Therapy
The use of immune reconstitution therapies (IRT) in patients with relapsing-remitting multiple sclerosis (RRMS) is associated with a prolonged period of freedom from relapses in the absence of continuously applied therapy. Cladribine tablets is a dis
Autor:
Pournamy Sarathchandran, Mona Thakre, Abubaker Al Madani, Reem Al Suwaidi, Nouf Saeed Al Talai, Jihad Inshasi
Publikováno v:
The Open Neurology Journal. 14:109-114
This case report describes a 32-year old Emirati patient with tumefactive multiple sclerosis (TMS) treated with a short course of cladribine tablets. The patient presented initially with acute onset of progressive gait unsteadiness, lower limb weakne
Autor:
Raed Alroughani, Jihad Inshasi, Mona Al Khawajah, Samar Farouk Ahmed, Yaser Al Malik, Jaber Alkhabouri, Ahmed Shatila, Salman Aljarallah, Edward J Cupler, Shireen Al Qureshi, Mona Thakre, Heba Elhasin, Aly Ezzat, Sherif Roushdy
Publikováno v:
Multiple sclerosis journal - experimental, translational and clinical. 8(1)
Background The prevalence of multiple sclerosis (MS) is increasing in Gulf Cooperation Council (GCC) countries. Multiple sclerosis contributes to significant burden on patients and caregivers. The pharmacological treatment in MS involves treating acu
Autor:
Abdullah Al-Asmi, Mona Thakre, Raed Alroughani, Dirk Deleu, Jaber Alkhaboury, Jihad Inshasi, Beatriz Canibano, Abdullah Alsalti, Amir Boshra, Samar Farouk Ahmed, Ahmed Shatila
Publikováno v:
Neurology and Therapy
This article describes consensus recommendations from an expert group of neurologists from the Arabian Gulf region on the management of relapsing multiple sclerosis (RMS) in the COVID-19 era. MS appears not to be a risk factor for severe adverse COVI
Autor:
Mona Thakre, Jihad Inshasi
Publikováno v:
Multiple Sclerosis and Related Disorders. 59:103591
Autor:
Mona Thakre, Jihad Inshasi
Publikováno v:
International Journal of Neuroscience. 121:393-398
Background: The prevalence of multiple sclerosis (MS) is rapidly changing. Objectives: To determine the prevalence and incidence of MS in Dubai, UAE. Methods: Data for all MS patients fulfilling McDonald criteria and registered in the Neurology Depar
Autor:
Mona Thakre
Publikováno v:
Journal of Neurology. 263:1234-1235
Publikováno v:
Journal of Neurology. 254:968-969